Breast Test Equipment
-
Manufactured by Cellanyx, LLCbased in USA
Risk stratification of early-stage breast cancer is an active area of research and several commercially available products that are based on genotypic classification. A vexing issue in breast cancer is carcinoma in situ – which has no metastatic potential. There are two sub types – Ductal Carcinoma in Situ (DCIS) and Lobular ...
-
Manufactured by Provista Diagnosticsbased in USA
A simple blood test to detect breast cancer with high accuracy in women with abnormal imaging findings. Coming in 2023 the only blood test to rule out breast cancer with >98% accuracy in women with suspicious imaging findings, irrespective of breast ...
-
Manufactured by Menssana Research Inc.based in USA
It takes 300 screening mammograms to discover one woman with breast cancer. A breath test might improve this very low yield. Researchers have known for many years that women with breast cancer have abnormal volatile organic compounds (VOCs) in their breath. Clinical studies at Menssana Research have shown that these breath VOCs can ...
-
Manufactured by Metaltronica S.p.A.based in ITALY
FIRST IN CLASS INNOVATIVE MOBILE MAMMOGRAPHY CLINIC FOR ALL BREAST SCREENING PROGRAMS. An all-in-one solution, now available in your neighborhood. 3D MAMMOGRAPHY BREAST, ULTRASOUND TESTING, ISTANT REPORTING. We believe life-saving early detection services should be available to every woman, everywhere. ...
-
based in INDIA
CanAssist Breast is a prognostic test developed by OncoStem that classifies the patients as ‘low-risk’ or ‘high-risk’ based on the patient’s risk of breast cancer recurrence over five years. CanAssist Breast provides information about the risk of recurrence of early-stage, hormone ...
-
based in USA
Screening can save lives and money by detecting cancer at its earliest most treatable stages when the 5yr survival approaches 90% versus just 10% in later stages ...
-
Manufactured by INOVIQ Ltdbased in AUSTRALIA
INOVIQ has three autoantibody tests in development for early detection of ovarian, breast and lung cancers. BARD1 autoantibody tests measure autoantibodies to variant BARD1 proteins in the blood and use a proprietary cancer-specific algorithm to combine these levels into a cancer score that identifies the presence or absence of a specific ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you